Monitoring Patients on Myelofibrosis Treatment
Faculty discuss the best strategies to monitor patients who are receiving treatment of MF as well as commenting on when it might be appropriate to switch therapies.
Read More
Treating Patients with Myelofibrosis and Anemia
Expert oncologists provide insights into how they might manage patients who present with anemia and myelofibrosis in their practice.
Read More
Myelofibrosis: FDA Approved Treatment Options and Updates from ASH 2023
Overview of the current FDA approved treatment options for the management of myelofibrosis as well as reviewing recent updates from ASH 2023 on the SIMPLIFY and PERSIST trials.
Read More
Polycythemia Vera: Choosing the Right Treatment
Panel experts talk about when to use cytoreductive therapy and which factors influence their treatment selection as well as reviewing how patients with PV are monitored.
Read More
Polycythemia Vera: Treatment Goals and Options
Faculty discuss the treatment goals for patients diagnosed with polycythemia vera and review treatment options for managing PV.
Read More
Polycythemia Vera: Assessing Risk and Genetic Testing
Experts discuss the optimal strategy for NGS testing, which alterations to test for and how to assess for risk when diagnosing and managing patients with polycythemia vera (PV).
Read More